{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:14:57Z","timestamp":1760177697772,"version":"build-2065373602"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ecl.2006.05.001","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:08:25Z","timestamp":1168423705000},"page":"611-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?"],"prefix":"10.1016","volume":"35","author":[{"given":"Preethi","family":"Srikanthan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Korenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2006.05.001_bib1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ecl.2006.05.001_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/meta.2002.31975","article-title":"Evaluation of assays available to measure free testosterone","volume":"51","author":"Morley","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2006.05.001_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2006.05.001_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2006.05.001_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2006.05.001_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0026-0495(90)90309-Z","article-title":"Regulation of sex hormone-binding globulin production by growth factors","volume":"39","author":"Plymate","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2006.05.001_bib13","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity in the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1992.tb00958.x","article-title":"Lack of linear relationship between hyperinsulinemia and hyperandrogenism","volume":"36","author":"Toscano","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib17","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0015-0282(02)03275-2","article-title":"Molecular progress in infertility: polycystic ovary syndrome","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1979.tb03077.x","article-title":"The inheritance of polycystic ovarian disease and a possible relationship to premature balding","volume":"11","author":"Ferriman","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jcem-71-6-1653","article-title":"Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women","volume":"71","author":"Falcone","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jcem-51-5-1054","article-title":"Luteinizing hormone receptors in ovarian follicles of patients with polycystic ovarian disease","volume":"51","author":"Rajaniemi","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2007-1016295","article-title":"Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome?","volume":"15","author":"Cataldo","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ecl.2006.05.001_bib23","first-page":"1053","article-title":"Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays","volume":"74","author":"Imse","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib24","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.001_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1210\/jcem-57-2-304","article-title":"Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women","volume":"57","author":"Evans","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1749-6632.1993.tb43860.x","article-title":"Body composition and regional fat distribution in polycystic ovarian syndrome: relationship to hormonal and metabolic profiles","volume":"687","author":"Bringer","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ecl.2006.05.001_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"issue":"4 Pt 1","key":"10.1016\/j.ecl.2006.05.001_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0029-7844(95)00250-U","article-title":"Body fat distribution in women with polycystic ovary syndrome","volume":"86","author":"Douchi","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2006.05.001_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-1009245","article-title":"Anthropometric variables and metabolism in polycystic ovarian disease","volume":"21","author":"Rebuffe-Scrive","year":"1989","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2006.05.001_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders","volume":"72","author":"Acien","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib33","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/oxfordjournals.humrep.a019512","article-title":"Effects of weight loss on the hormonal profile in obese, infertile women","volume":"11","author":"Hollmann","year":"1996","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2006.05.001_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/humrep\/12.suppl_1.72","article-title":"Influences of weight, body fat patterning and nutrition on the management of PCOS","volume":"12","author":"Lefebvre","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.001_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0026-0495(03)00031-3","article-title":"Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome","volume":"52","author":"Goodarzi","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2006.05.001_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib38","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women","volume":"83","author":"Diamond","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"issue":"2 Pt 1","key":"10.1016\/j.ecl.2006.05.001_bib41","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ecl.2006.05.001_bib42","first-page":"577","article-title":"Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib43","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2006.05.001_bib44","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib45","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib48","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ecl.2006.05.001_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2006.05.001_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2004.03.002","article-title":"The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals","volume":"33","author":"Reaven","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2006.05.001_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.001_bib54","first-page":"1241","article-title":"Defects in beta-cell function functional ovarian hyperandrogenism","volume":"76","author":"O'Meara","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib55","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.001_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.HYP.36.2.226","article-title":"High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease","volume":"36","author":"Jeppesen","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2006.05.001_bib57","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.1997.03540430051032","article-title":"A prospective study of body mass index, weight change, and risk of stroke in women","volume":"277","author":"Rexrode","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.001_bib59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ecl.2006.05.001_bib60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib61","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib62","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.001_bib63","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in\u00a0young women with polycystic ovary syndrome","volume":"90","author":"Kravariti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/jc.2002-020386","article-title":"Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome","volume":"88","author":"Paradisi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib65","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2006.05.001_bib66","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib67","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib68","doi-asserted-by":"crossref","first-page":"23251","DOI":"10.1016\/S0021-9258(18)54489-6","article-title":"Stimulation of endothelin-1 gene expression by insulin in endothelial cells","volume":"266","author":"Oliver","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ecl.2006.05.001_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1067\/mva.2002.121066","article-title":"Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis","volume":"35","author":"Meissner","year":"2002","journal-title":"J Vasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2006.05.001_bib70","first-page":"85","article-title":"Fibrinolytic factors and atherothrombotic events: epidemiological evidence","volume":"32","author":"Folsom","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib71","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.2002-021391","article-title":"Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity","volume":"88","author":"Dereli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.ecl.2006.05.001_bib72","first-page":"1353","article-title":"Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS)","volume":"14","author":"Macut","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib73","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2006.05.001_bib75","first-page":"707","article-title":"[Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome]","volume":"129","author":"Benitez","year":"2001","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.ecl.2006.05.001_bib76","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib77","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-2217","article-title":"Dyslipidemia and metabolic syndrome in the\u00a0sisters of women with polycystic ovary syndrome","volume":"90","author":"Sam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1463-1326.2002.00214.x","article-title":"The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue","volume":"4","author":"Anderson","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib79","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ecl.2006.05.001_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.1.01868","article-title":"Evidence for altered adipocyte function in polycystic ovary syndrome","volume":"152","author":"Carmina","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2006.05.001_bib81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1447-0756.2001.tb01241.x","article-title":"Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility","volume":"27","author":"Sills","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ecl.2006.05.001_bib82","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib83","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2362.1999.00572.x","article-title":"Changes of plasma total homocysteine levels during the menstrual cycle","volume":"129","author":"Tallova","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ecl.2006.05.001_bib84","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/09513590400027265","article-title":"Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ecl.2006.05.001_bib85","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2001-012056","article-title":"Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome","volume":"87","author":"Randeva","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2002-23489","article-title":"Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome","volume":"110","author":"Vrbikova","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ecl.2006.05.001_bib87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM200407153510318","article-title":"C-reactive protein and coronary heart disease","volume":"351","author":"Ridker","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib88","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2265.1998.00492.x","article-title":"Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women","volume":"49","author":"Rodin","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.hjr.0000140714.79273.c9","article-title":"Coronary risk in South Asians: role of ethnicity and blood sugar","volume":"11","author":"Aarabi","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ecl.2006.05.001_bib91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ecl.2006.05.001_bib92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2006.05.001_bib93","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib94","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/01.CIR.0000091114.36254.F3","article-title":"Sex hormone levels and risk of cardiovascular events in postmenopausal women","volume":"108","author":"Rexrode","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.001_bib95","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib96","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2006.05.001_bib97","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib98","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib99","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib100","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2006.05.001_bib101","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib102","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/humrep\/14.8.1949","article-title":"Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome","volume":"14","author":"Tiras","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)53699-1","article-title":"Clinical signs of androgen excess as risk factors for coronary artery disease","volume":"54","author":"Wild","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2006.05.001_bib106","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2\u00a0diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.001_bib107","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib108","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/humrep\/deh700","article-title":"Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study","volume":"20","author":"Kilicdag","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2006.05.001_bib109","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2006.05.001_bib111","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diabetes.51.4.1110","article-title":"Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart","volume":"51","author":"Sidell","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.001_bib112","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:28:42Z","timestamp":1760174922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852906000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889852906000387"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2006.05.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2006.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}